Print

NeuroVive Pharmaceutical AB First Day of Trading on NASDAQ OMX Stockholm  
4/10/2013 11:27:36 AM

Lund (Sweden) – April 10, 2013, NeuroVive Pharmaceutical AB (publ), a leading mitochondrial medicine company, announces that its admission to NASDAQ OMX Stockholm will become effective and trading of the shares will start at 09.00 am (CET) today, 10th April 2013.
//-->